Elissa is a senior laboratory technician with more than 15 years of experience working on preclinical cancer therapeutic development. She previously studied the role of MKK signaling in cancer and other vascular diseases, specifically retinopathies and peripheral vascular disease. She has experience in drug administration studies, surgical interventions and high-throughput genetic screening. Elissa joined the Grohar lab in 2016 to begin focusing on preclinical therapeutics for Ewing sarcoma.
Susan earned a B.S. in chemistry with an emphasis in biochemistry and a Master’s in business administration from Grand Valley State University. She has worked at VARI in the field of cancer biology for 13 years, and joined the Grohar Laboratory in September 2015.
Matt graduated with a B.S. in biology from the University of North Carolina at Chapel Hill. He subsequently attended Marshall University where he earned an M.S. in cancer biology. Matt is a graduate student at Vanderbilt University enrolled in the training program in the Department of Cancer Biology. He joined the Grohar lab in May 2012 and moved with the lab to VARI in July 2015. He is a Ph.D. candidate whose research focuses on developing trabectedin as a treatment for Ewing sarcoma.
Jennifer is earning a B.S. in biomedical sciences with an emphasis in chemistry at Grand Valley State University. She joined the Grohar Laboratory in June 2016 as part of the Frederik and Lena Meijer Student Internship Program and is continuing in the lab with a focus on characterizing novel drug combinations for Ewing sarcoma.